Ropren® is a polyprenol preparation from coniferous plants that ameliorates cognitive deficiency in a rat model of beta-amyloid peptide-(25–35)-induced amnesia

This publication has 21 references indexed in Scilit:

• Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
  Nature Reviews Drug Discovery, 2009
• Possible anxiolytic effect of two extracts of Passiflora quadrangularis L. in experimental models
  Phytotherapy Research, 2007
• Current strategies for the treatment of Alzheimer’s disease and other tauopathies
  Expert Opinion on Therapeutic Targets, 2006
• Involvement of 5-HT_1?receptors in passive avoidance learning in intact and ovariectomized female rats
  Acta Physiologica Hungarica, 2004
• New perspectives for (S)-dolichol and (S)-nordolichol synthesis and biological functions
  Biogerontology, 2003
• New drugs for Alzheimer's disease and other dementias
  The British Journal of Psychiatry, 2002
• Drug treatment in dementia
  Current Opinion in Psychiatry, 2001
• Bacterial Degradation of Natural and Synthetic Rubber
  Biomacromolecules, 2001
• Exploratory behaviour and grooming after repeated restraint and chronic mild stress: effect of desipramine
  European Journal of Pharmacology, 2000
• β-Amyloid(Phe(SO3H)24)25–35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation
  Behavioural Brain Research, 1998